Simon Langdon

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	12661	3712
h-endeksi	62	31
i10-endeksi	166	72

820

410

205

615

198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202533 52 45 51 40 47 37 57 82 88 81 123 158 128 172 199 206 225 187 207 224 259 247 291 328 396 464 488 623 628 668 692 653 636 688 806 789 670 622 136

Genel erişim

Tümünü görüntüle

38 makale

7 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

David J HarrisonUniversity of St Andrewsnucana.com üzerinde doğrulanmış e-posta adresine sahip
Andrew H SimsUniversity of Edinburghed.ac.uk üzerinde doğrulanmış e-posta adresine sahip
John BartlettDirector of Transformative Pathology, Ontario Institute for Cancer Researchoicr.on.ca üzerinde doğrulanmış e-posta adresine sahip
Alistair WilliamsDepartment of Pathology, University of Edinburghed.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Yusuf DeeniProfessor of Molecular Biology and Biomedicine, Department of Microbiology and Biotechnologyabertay.ac.uk üzerinde doğrulanmış e-posta adresine sahip
V Anne SmithSchool of Biology, University of St Andrewsst-andrews.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Hilal Shahid KhalilMS| PhD | MLS (ASCP)bhmcny.org üzerinde doğrulanmış e-posta adresine sahip
Antonis KoussounadisUniversity of St Andrewsst-andrews.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Igor GoryaninHenrik Kacser Chair in Systems Biologyinf.ed.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Oystein fodstadProfessor emeritus, Oslo University Hospital, University of Oslorr-research.no üzerinde doğrulanmış e-posta adresine sahip
Charlotte K Y NgHumanitas University and University of Bernunibe.ch üzerinde doğrulanmış e-posta adresine sahip
Robert ClarkeThe Hormel Institute, University of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Sarah J AitkenYale University (US) & University of Cambridge (UK)yale.edu üzerinde doğrulanmış e-posta adresine sahip
Anatoly SorokinOkinawa Institute of Science and Technologyoist.jp üzerinde doğrulanmış e-posta adresine sahip
Amanda O'DonnellMolecular Cancer Studies, University of Manchestermanchester.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Epie BovenHoogleraar Medische Oncologie, VUmc, Amsterdamvumc.nl üzerinde doğrulanmış e-posta adresine sahip
TOSHIYASU TANIGUCHIFred Hutchinson Cancer Research Center, Tokai University School of Medicineumin.ac.jp üzerinde doğrulanmış e-posta adresine sahip
Alexey LarionovLecturer in Bioinformatics, Cranfield University, UKcranfield.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Adrian L HarrisProfessor of Medical Oncology, Oxford Universityoncology.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Elad KatzUniversity of Dundeedundee.ac.uk üzerinde doğrulanmış e-posta adresine sahip

Takip et

Simon Langdon

University of Edinburgh, Reader

ed.ac.uk üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Cancer research


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system A Koussounadis, SP Langdon, IH Um, DJ Harrison, VA Smith Scientific reports 5 (1), 10775, 2015	754	2015
Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a Novel Drug … MFG Stevens, JA Hickman, SP Langdon, D Chubb, L Vickers, R Stone, ... Cancer research 47 (22), 5846-5852, 1987	550	1987
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013	542	2013
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma W Sakai, EM Swisher, C Jacquemont, KV Chandramohan, FJ Couch, ... Cancer research 69 (16), 6381-6386, 2009	369	2009
Characterization and properties of nine human ovarian adenocarcinoma cell lines SP Langdon, SS Lawrie, FG Hay, MM Hawkes, A McDonald, IP Hayward, ... Cancer research 48 (21), 6166-6172, 1988	313	1988
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer JMS Bartlett, SP Langdon, BJB Simpson, M Stewart, D Katsaros, ... British journal of cancer 73 (3), 301-306, 1996	261	1996
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases SJ Aitken, JS Thomas, SP Langdon, DJ Harrison, D Faratian Annals of Oncology 21 (6), 1254-1261, 2010	255	2010
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor–positive patients JF Smyth, C Gourley, G Walker, MJ MacKean, A Stevenson, ... Clinical Cancer Research 13 (12), 3617-3622, 2007	244	2007
New strategies for targeting the hypoxic tumour microenvironment in breast cancer C Ward, SP Langdon, P Mullen, AL Harris, DJ Harrison, CT Supuran, ... Cancer treatment reviews 39 (2), 171-179, 2013	234	2013
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup A Bowman, H Gabra, SP Langdon, A Lessells, M Stewart, A Young, ... Clinical cancer research 8 (7), 2233-2239, 2002	213	2002
Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen AJM O’Donnell, KG Macleod, DJ Burns, JF Smyth, SP Langdon Endocrine-related cancer 12 (4), 851-866, 2005	204	2005
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma SL Cooke, CKY Ng, N Melnyk, MJ Garcia, T Hardcastle, J Temple, ... Oncogene 29 (35), 4905-4913, 2010	199	2010
Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab D Faratian, A Goltsov, G Lebedeva, A Sorokin, S Moodie, P Mullen, C Kay, ... Cancer research 69 (16), 6713-6720, 2009	197	2009
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models C Xintaropoulou, C Ward, A Wise, H Marston, A Turnbull, SP Langdon Oncotarget 6 (28), 25677, 2015	192	2015
Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo T Sethi, S Langdon, J Smyth, E Rozengurt Cancer Research 52 (9_Supplement), 2737s-2742s, 1992	185	1992
Cancer cell culture SP Langdon, SP Langdon Springer, 2003	179	2003
Expression of the heat shock protein HSP27 in human ovarian cancer. SP Langdon, GJ Rabiasz, GL Hirst, RJ King, RA Hawkins, JF Smyth, ... Clinical cancer research: an official journal of the American Association …, 1995	178	1995
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer K Macleod, P Mullen, J Sewell, G Rabiasz, S Lawrie, E Miller, JF Smyth, ... Cancer research 65 (15), 6789-6800, 2005	176	2005
Implantable biosensors and their contribution to the future of precision medicine M Gray, J Meehan, C Ward, SP Langdon, IH Kunkler, A Murray, D Argyle The Veterinary Journal 239, 21-29, 2018	154	2018
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer HR Hendriks, HH Fiebig, R Giavazzi, SP Langdon, JM Jimeno, ... Annals of Oncology 10 (10), 1233-1240, 1999	145	1999

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar